The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Patent Drug Market Research Report 2024
Synopsis
A patent medicine is typically protected and advertised by a trademark and trade name (and sometimes a patent) and claimed to be effective against minor disorders and symptoms.
Global Patent Drug market is projected to reach US$ 1507000 million in 2029, increasing from US$ 1071000 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Patent Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Patent Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Segment by Type
Oral
Injection
Other
Segment by Application
Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Patent Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
A patent medicine is typically protected and advertised by a trademark and trade name (and sometimes a patent) and claimed to be effective against minor disorders and symptoms.
Global Patent Drug market is projected to reach US$ 1507000 million in 2029, increasing from US$ 1071000 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Patent Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Patent Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Segment by Type
Oral
Injection
Other
Segment by Application
Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Patent Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patent Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Patent Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Patent Drug Market Perspective (2018-2029)
2.2 Patent Drug Growth Trends by Region
2.2.1 Global Patent Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Patent Drug Historic Market Size by Region (2018-2023)
2.2.3 Patent Drug Forecasted Market Size by Region (2024-2029)
2.3 Patent Drug Market Dynamics
2.3.1 Patent Drug Industry Trends
2.3.2 Patent Drug Market Drivers
2.3.3 Patent Drug Market Challenges
2.3.4 Patent Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patent Drug Players by Revenue
3.1.1 Global Top Patent Drug Players by Revenue (2018-2023)
3.1.2 Global Patent Drug Revenue Market Share by Players (2018-2023)
3.2 Global Patent Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Patent Drug Revenue
3.4 Global Patent Drug Market Concentration Ratio
3.4.1 Global Patent Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patent Drug Revenue in 2022
3.5 Patent Drug Key Players Head office and Area Served
3.6 Key Players Patent Drug Product Solution and Service
3.7 Date of Enter into Patent Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patent Drug Breakdown Data by Type
4.1 Global Patent Drug Historic Market Size by Type (2018-2023)
4.2 Global Patent Drug Forecasted Market Size by Type (2024-2029)
5 Patent Drug Breakdown Data by Application
5.1 Global Patent Drug Historic Market Size by Application (2018-2023)
5.2 Global Patent Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Patent Drug Market Size (2018-2029)
6.2 North America Patent Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Patent Drug Market Size by Country (2018-2023)
6.4 North America Patent Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Patent Drug Market Size (2018-2029)
7.2 Europe Patent Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Patent Drug Market Size by Country (2018-2023)
7.4 Europe Patent Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patent Drug Market Size (2018-2029)
8.2 Asia-Pacific Patent Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Patent Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Patent Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Patent Drug Market Size (2018-2029)
9.2 Latin America Patent Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Patent Drug Market Size by Country (2018-2023)
9.4 Latin America Patent Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patent Drug Market Size (2018-2029)
10.2 Middle East & Africa Patent Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Patent Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Patent Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Patent Drug Introduction
11.1.4 Pfizer Revenue in Patent Drug Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Patent Drug Introduction
11.2.4 Roche Revenue in Patent Drug Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Patent Drug Introduction
11.3.4 Sanofi Revenue in Patent Drug Business (2018-2023)
11.3.5 Sanofi Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Patent Drug Introduction
11.4.4 Johnson & Johnson Revenue in Patent Drug Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Detail
11.5.2 Merck & Co. (MSD) Business Overview
11.5.3 Merck & Co. (MSD) Patent Drug Introduction
11.5.4 Merck & Co. (MSD) Revenue in Patent Drug Business (2018-2023)
11.5.5 Merck & Co. (MSD) Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Patent Drug Introduction
11.6.4 Novartis Revenue in Patent Drug Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Patent Drug Introduction
11.7.4 AbbVie Revenue in Patent Drug Business (2018-2023)
11.7.5 AbbVie Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Patent Drug Introduction
11.8.4 Gilead Sciences Revenue in Patent Drug Business (2018-2023)
11.8.5 Gilead Sciences Recent Development
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Detail
11.9.2 GlaxoSmithKline (GSK) Business Overview
11.9.3 GlaxoSmithKline (GSK) Patent Drug Introduction
11.9.4 GlaxoSmithKline (GSK) Revenue in Patent Drug Business (2018-2023)
11.9.5 GlaxoSmithKline (GSK) Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Patent Drug Introduction
11.10.4 Amgen Revenue in Patent Drug Business (2018-2023)
11.10.5 Amgen Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Patent Drug Introduction
11.11.4 AstraZeneca Revenue in Patent Drug Business (2018-2023)
11.11.5 AstraZeneca Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Patent Drug Introduction
11.12.4 Bristol-Myers Squibb Revenue in Patent Drug Business (2018-2023)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Detail
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Patent Drug Introduction
11.13.4 Eli Lilly Revenue in Patent Drug Business (2018-2023)
11.13.5 Eli Lilly Recent Development
11.14 Teva
11.14.1 Teva Company Detail
11.14.2 Teva Business Overview
11.14.3 Teva Patent Drug Introduction
11.14.4 Teva Revenue in Patent Drug Business (2018-2023)
11.14.5 Teva Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Patent Drug Introduction
11.15.4 Bayer Revenue in Patent Drug Business (2018-2023)
11.15.5 Bayer Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Patent Drug Introduction
11.16.4 Novo Nordisk Revenue in Patent Drug Business (2018-2023)
11.16.5 Novo Nordisk Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Detail
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Patent Drug Introduction
11.17.4 AbbVie Revenue in Patent Drug Business (2018-2023)
11.17.5 AbbVie Recent Development
11.18 Takeda
11.18.1 Takeda Company Detail
11.18.2 Takeda Business Overview
11.18.3 Takeda Patent Drug Introduction
11.18.4 Takeda Revenue in Patent Drug Business (2018-2023)
11.18.5 Takeda Recent Development
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Detail
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Patent Drug Introduction
11.19.4 Boehringer Ingelheim Revenue in Patent Drug Business (2018-2023)
11.19.5 Boehringer Ingelheim Recent Development
11.20 Takeda
11.20.1 Takeda Company Detail
11.20.2 Takeda Business Overview
11.20.3 Takeda Patent Drug Introduction
11.20.4 Takeda Revenue in Patent Drug Business (2018-2023)
11.20.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
